Related Experiment Video
Updated: May 14, 2026
08:00
Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Progress and challenges in cystic fibrosis gene editing
Jacob Witten1, Marie Egan2, Anna Cereseto3
1Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Summary
Gene editing offers a potential permanent cure for cystic fibrosis (CF) by correcting the CFTR gene. While progress is rapid, challenges in delivery and genetic diversity remain before clinical application.
Area of Science:
- Biotechnology
- Genetics
- Medical Research
Background:
- Gene editing presents a unique therapeutic strategy for permanently curing cystic fibrosis (CF).
- Correction of the CFTR gene aims to restore native function in CF patients.
- Significant advancements in gene editing technologies are being made.
Purpose of the Study:
- To review the progress and challenges of gene editing for cystic fibrosis.
- To discuss the evolving landscape of genome editing tools.
- To highlight delivery system advancements and remaining hurdles for clinical translation.
Main Methods:
- Review of recent developments in gene editing technologies.
- Analysis of challenges in delivering gene editing tools to target cells.
- Discussion of strategies for addressing genetic heterogeneity in CF.
- Synthesis of information presented at the 20th ECFS Basic Science Conference.
Main Results:
- New gene editors show improved efficiency in correcting CFTR mutations.
- Delivery methods, including inhaled and in utero approaches, are advancing.
- Logistical challenges persist due to the genetic diversity of the CF population.
Conclusions:
- Gene editing holds immense promise for a permanent cure for cystic fibrosis.
- Delivery systems and addressing genetic heterogeneity are key areas for future research.
- While promising, gene editing therapeutics for CF are not yet clinically available.
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:59CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
00:49What is Genetic Engineering?
Overview
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:28CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...